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ORIGINAL ARTICLE

Health and Social Problems Associated With Prescription Opioid Misuse
Among a Diverse Sample of Substance-Using MSM
Mance E. Buttram, Steven P. Kurtz, Hilary L. Surratt and Maria A. Levi-Minzi
Center for Applied Research on Substance Use and Health Disparities, Nova Southeastern University, Miami,
Florida, USA
tidrug use, including prescription drugs, has also been
evidenced among MSM, where prescription drug misusers were significantly more likely to report recent
use of other drugs including cocaine, ecstasy, methamphetamine, and heroin, in addition to increased sexual
risk behavior (Benotsch et al., 2011). Perhaps the most
alarming finding from that study was that opioid analgesics were the most commonly misused prescription
drug (Benotsch et al., 2011). Prescription opioids are
Schedule II controlled substances with high abuse potential (Wu et al., 2012), are highly addictive (SAMHSA,
2006), and are the class of drug most often associated with
drug mortality (Benotsch et al., 2011). Kelly and Parsons
(2013) found that about 11% of prescription drug misusing MSM reported recent use of pain killers. Further, a
study of methamphetamine-using MSM, found that 4.2%
of participants also reported misusing the prescription opiR
(Halkitis, Moeller, Siconolfi, Jerome, &
oid, OxyContin
Rogers, 2008). To date, these are the only apparent articles in the literature that describe prescription opioid misuse among MSM, even though the misuse of prescription
opioids in the United States has been escalating since the
early 1990s (SAMHSA, 2012; SAMHSA, 2011).
Much of the literature examining health and social disparities among MSM suggests that greater rates of substance use (Cochran & Mays, 2008), arrest history (Kurtz,
2008), victimization (Herek & Sims, 2008; Purcell,
Patterson, & Spikes, 2008), and mental distress (Cochran
& Mays, 2008; Mills et al., 2004) are present among
this population compared to other men. Moreover, many
of these health and social problems have been found
to be associated with the misuse of prescription opioids
as well. Samples of chronic pain patients, street-based
substance users, MSM, and opioid-dependent treatment
clients report problems related to mental distress (Cicero,
Surratt, Kurtz, Ellis, & Inciardi, 2012; Pergolizzi et al.,
2012), other substance abuse (Cicero et al., 2011; Cicero

This study examines associations between prescription
opioid misuse and demographics, substance use, sexual behavior, and related health and social problems.
Baseline data were collected between 2008 and 2010
from 515 high risk men who have sex with men, ages
18–55, in the Miami-Ft. Lauderdale metropolitan area
who reported heavy substance use and HIV risk in the
past 90 days. Prescription opioid misuse was associated
with other substance use, drug injection, substance dependence, and history of arrest. Implications, limitations, and directions for future study are discussed.
Keywords

Prescription drugs, opioid, MSM, substance use

INTRODUCTION

Evidence suggests that men who have sex with men
(MSM) are more likely to misuse prescription drugs
(Kelly & Parsons, 2013) and are more likely to experience
problems suggestive of substance dependence (MackesyAmiti, Fendrich, & Johnson, 2009) than adults in the
general population. However, most research on prescription drug misuse among MSM is focused on either the
misuse of erectile dysfunction medications (Kim, Kent,
& Klausner, 2002; Mansergh et al., 2006; Sherr, Bolding, Maguire, & Elford, 2000) or the misuse of prescription drugs in general (Benotsch, Martin, Koester,
Cejka, & Luckman, 2011; Kelly & Parsons, 2010, 2013;
Mackesy-Amiti et al., 2009; Mackesy-Amiti, Fendrich, &
Johnson, 2010). Among the latter is evidence of increased
sexual risk behavior among MSM who misuse prescription drugs, compared to MSM who do not (Benotsch et al.,
2011; Kelly & Parsons, 2013).
While not specific to MSM, research finds that the misuse of prescription drugs is associated with the use of
a variety of additional substances (Lankenau, Schrager,
et al., 2012; Wu, Woody, Yang, & Blazer, 2012). Mul-
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et al., 2012; Pergolizzi et al., 2012), legal issues and the
law (Kurtz, 2008; Pergolizzi et al., 2012), victimization
(Pergolizzi et al., 2012; Surratt, Inciardi, & Kurtz, 2006),
and hepatitis A, B, or C infection (Strassels, 2009).
The growing epidemic of prescription opioid misuse
and related problems can be in part attributed to increased
prescribing, availability, accessibility, and accepted medical use (Hasan & Hasan, 2011; Lankenau, Teti, et al.,
2012; McCabe, Teter, & Boyd, 2006). The National Survey of Drug Use and Health found that the numbers of
new, nonmedical users of prescription opioids increased
from 600,000 in 1990 to 2 million in 2010. Among individuals ages 12 and over, 17.3% reported first-time
substance use with an prescription opioid in 2010 and
prescription opioids had the second largest number of
past year initiates following marijuana (SAMSHA, 2011).
Drug Abuse Warning Network data also reflect these increases, with abuse-related emergency department visits involving prescription opioids increasing by 156%
between 2004 and 2011 (Center for Behavioral Health
Statistics and Quality, 2012). Similar increases are reflected in drug abuse treatment admissions data, with
past year admissions for prescription opioids increasing
from 360,000 in 2002 to 754,000 in 2010 (SAMSHA,
2011).
Further exacerbating the problem of prescription opioid misuse is that nonoral routes of administration
have been documented in several populations (Davis &
Johnson, 2008; Havens, Walker, & Leukefeld, 2007;
McCabe, Boyd, Cranford, & Teter, 2009; McCabe,
Cranford, Boyd, & Teter, 2007; Young, Havens, & Leukefeld, 2010). Such alternative routes of administration,
such as injection, allow for faster drug delivery and onset, creating more intensified effects and increased abuse
liability (Budman, Grimes Serrano, & Butler, 2009). Injection of prescription opioids also facilitates transmission
of HIV (Surratt, Kurtz, & Cicero, 2011). While no studies of non-oral routes of prescription drug abuse among
MSM are apparent in the literature, research shows injection drug use (IDU) is not uncommon among MSM and
that the most commonly injected substances are methamphetamine and cocaine (Ghanem et al., 2011; Gorman &
Carroll, 2000; Ibañez, Purcell, Stall, Parsons, & Gómez,
2005; O’Connell et al., 2004; Semple, Strathdee, Zians, &
Patterson, 2012; Stall & Purcell, 2000).
These findings demonstrate the need to further investigate the problem of prescription opioid misuse and related
health and social problems among high risk MSM. Because literature suggests that MSM are more likely to misuse prescription drugs than other men (Kelly & Parsons,
2013), it is not implausible that this population would
also have higher rates of prescription opioid misuse than
men in the general population. With this in mind, and because of the severity of health and social problems that are
generally associated with prescription opioid misuse, we
sought to examine predictors of prescription opioid misuse among a sample of high risk substance-using MSM in
South Florida.

METHODS

Data are drawn from baseline assessments of 515 MSM
participating in a risk reduction intervention trial conducted in the Miami-Ft. Lauderdale Metropolitan Area.
The study is a randomized clinical trial testing the efficacy
of a four-session small group discussion intervention compared to a single-session individual counseling condition,
both of which are based on theories of resilience and psychological empowerment (Fergus & Zimmerman, 2005;
Zimmerman, 1995). Participants were recruited into the
study between November 2008 and October 2010. Multiple recruitment methods were employed, including direct
outreach, participant referral, and internet and print media.
Eligible men were between the ages of 18 and 55; reported
recent (past 90 days) unprotected anal intercourse (UAI)
with a nonmonogamous partner(s); and met one or more
of three substance use inclusion criteria: binge drinking
(five or more drinks) or drug use, excluding marijuana,
at least three times in the past month; or using marijuana
on 20 or more days in the past month. Research protocols were approved by the University of Delaware’s (predecessor institution) and Nova Southeastern University’s
Institutional Review Boards.

Site

The Miami-Ft. Lauderdale metropolitan area is a wellknown migration destination for MSM, with the second highest ratio of same-sex households among large
metropolitan areas in the nation (Smith & Gates, 2001,
August 22). Further, Florida has been at the center of
the nation’s prescription opioid epidemic for the past
decade, leading the nation in numbers of illegitimate pain
clinics (Gillette, 2012; Hall, 2012). Prior to new legislation in 2011 designed to better control the distribution and prescribing of prescription opioids, 90 of the
nation’s top 100 oxycodone-purchasing doctors resided
in Florida (Gillette, 2012). In addition, Miami reports
the highest AIDS rates and HIV incidence in the United
States (Centers for Disease Control and Prevention, 2009)
and almost half (45%) of HIV-positive MSM in a recent Miami study were unaware of their infection (CDC,
2010).
The project was housed in two field offices, one in
Wilton Manors, a suburb of Ft. Lauderdale and one in
Miami Beach. Each participant was screened for eligibility, followed by informed consent and enrollment and locator data collection. Men reporting HIV-negative status
were also offered confidential testing. The baseline interview session was scheduled about two weeks from enrollment, so that HIV test results could be given to men who
elected testing during the same visit. All interviews were
conducted in private offices using computer-assisted faceto-face interviews. Participants received HIV and drug
education literature, condoms, and a $50 stipend upon
completion of the baseline activities. Baseline interviews
lasted about two hours.
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Measures

Data Analyses

The primary instrumentation for the interviews was the
Global Appraisal of Individual Needs (GAIN) which has
eight core sections (demographics, substance use, physical health, risk behaviors, mental health, environment,
legal involvement, and vocational attainment), with each
containing questions on the recency of problems, breadth
of symptoms, and recent health behavior frequencies in
days or times (Dennis, 2006).
Substance use measures included past 90 day frequency of use of each substance, including the nonmedical use of prescription opioids, specifically asking, “In
the past 90 days, how many days did you use a prescription painkiller, opioid, or analgesic not as prescribed?”.
Substance dependence was assessed by the endorsement
of three or more of seven Diagnostic and Statistical Manual of Mental Disorders, 4th edition, revised (DSM-IVR)
symptoms during the past year (e.g., needing more drug to
get the same effect, experiencing withdrawal symptoms,
and being unable to quit or cut down).
An extensive battery of sexual behavior questions specific to MSM included past 90 day frequencies of receptive and insertive UAI. Because study eligibility criteria
included UAI during the past 90 days, sexual risk behavior measures were dichotomized at the 66th percentile to
divide the sample into higher and lower risk subgroups
in these analyses. Participant HIV status was assessed by
self-report, and seropositivity was verified with a notice
of diagnosis or antiretroviral prescription.
Mental distress was assessed using the General Mental Distress Scale, which is comprised of past year DSMIVR symptom counts for depression (9 items), anxiety
(12 items), and somatic disorders (4 items). This scale
is reducible to classifications indicating clinical significance (subclinical, moderate, and severe) (Dennis, 2006)
and was further dichotomized in the analyses presented
here into “severe” and “not severe.” Alpha reliability coefficients for the depression, anxiety, and somaticism subscales in this study were .822, .829, and .706, respectively.
Victimization was assessed by affirmative responses to
the following events: being attacked with a weapon or being beaten so as to cause bruises, cuts, or broken bones
(physical abuse); being forced to participate in sexual acts
against one’s will (sexual abuse); or being made to feel
very bad about oneself or one’s life (emotional abuse). For
analysis, we used a summary measure: any lifetime abuse
vs. no abuse.
Lifetime counts of substance abuse treatment were assessed with the question, “How many times in your life
have you been admitted to detox, treatment, or counseling for your use of alcohol or any drugs?” Arrest history
was assessed with the question, “In your lifetime, how
many times have you been arrested, charged with a crime
and booked?” Health care coverage was assessed with the
question, “Are your medical expenses covered by any type
of insurance, court, or health program?” Drug injection
history was assessed with the following question, “When
was the last time (if ever) that you used a needle to inject
drugs (including steroids)?”

All analyses were conducted using IBM SPSS Statistics
version 20. Descriptive statistics for the entire study sample were calculated for the variables of interest including
demographics, substance use, sexual risk behavior, and
health and social characteristics. Bivariate logistic regression models were constructed to predict recent prescription opioid misuse. Potential predictors included in the
bivariate models included demographics, other drug use,
sexual risk behavior, and health and social characteristics.
Those measures that exhibited significant associations in
the bivariate models were included in a multivariate logistic regression model.
RESULTS

Demographics and substance use characteristics of the
sample are shown in Table 1. The racially/ethnically
diverse sample was 25.8% Hispanic (N = 133), 21.0%
African American/Black (N = 108), 48.5% Caucasian
(N = 250), and 4.7% “other” race/ethnicity (N = 24).
The mean age was 38.93 (SD = 9.64) years. Sixteen
TABLE 1. Description of study sample (N = 515)

Race/Ethnicity
Hispanic
African American/Caribbean
Caucasian/White
Other
Age (mean; SD)
Education (16 or more years)
Employed full-time
Health care coverage
Substance use (past 90 days)
Binge drinking
Marijuana
Powder cocaine
Rx sedatives
Methamphetamine
Rx opioids
Crack cocaine
Ecstasy
Gamma hydroxybutyrate
Rx stimulants
Ketamine
Heroin
Drug injector (past year)
Drug injector (past 90 days)
Sexual risk behavior (past 90 days)
Partners
UAI times
Health and social characteristics
HIV-positive
Substance dependence
Substance abuse treatment history
Severe mental distress
Victimization history
Arrest history

N

%

133
108
250
24
38.93
165
134
323

25.8%
21.0%
48.5%
4.7%
(9.64)
32.0%
26.0%
62.7%

421
336
231
177
132
129
104
93
72
27
15
15
82
66

81.7%
65.2%
44.9%
34.4%
25.6%
25.0%
20.2%
18.1%
14.0%
5.2%
2.9%
2.9%
15.9%
12.8%

13.25
22.58
250
320
198
298
413
332

(18.58)
(35.41)
48.5%
62.1%
38.4%
57.9%
80.2%
64.5%
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or more years of education were reported by 32.0%
(N = 165), 26.0% (N = 134) reported being employed full-time, and 62.7% (N = 323) had health care
coverage.
Participants reported using a host of substances during
the past 90 days. A majority of participants reported binge
drinking (81.7%; N = 421) and marijuana use (65.2%;
N = 336). The use of stimulant and club drugs was also
prevalent in the sample, with participants reporting the
use of powder cocaine (44.9%; N = 231), crack cocaine
(20.2%; N = 104), methamphetamine (25.6%; N = 132),
and ecstasy (18.1%; N = 93) in the past 90 days. Smaller
numbers of participants reported the use of heroin (2.9%;
N = 15), and GHB (14.0%; N = 72). The class of prescription drugs most commonly misused was sedatives
(34.4%; N = 177), followed by opioids (25.0%; N = 129),
and stimulants (5.2%; N = 27). IDU during the past year
(15.9%; N = 82) and during the past 90 days (12.8%;
N = 66) was also reported.
During the past 90 days, participants reported a mean
of 13.25 (SD 18.58) sex partners and 22.58 (SD 35.41)
UAI frequency. Almost half the sample (48.5%; N = 250)
reported HIV-positive serostatus. A number of men met
criteria for substance dependence (62.1%; N = 320), reported substance abuse treatment history (38.4%; N =
198), met criteria for severe mental distress (57.9%; N =
298), or reported victimization (80.2%; N = 413), or arrest histories (64.5%; N = 332).
Bivariate logistic regression models predicting recent
prescription opioid misuse are shown in Table 2. No significant associations with prescription opioid misuse were
found with regard to race/ethnicity or age. Past 90 day
binge drinking (OR = 2.938; 95% CI = 1.513, 5.707; p =
.001) and the use of powder cocaine (OR = 2.329; 95%
CI = 1.546, 3.501; p < .000), crack cocaine (OR = 1.810;
95% CI = 1.137, 2.883; p = .012), or heroin (OR = 6.403;
95% CI = 2.146, 19.104; p = .001) predicted higher odds
of prescription opioid misuse, as was IDU (OR = 2.023;
95% CI = 1.175, 3.483; p = .011). No measure of sexual risk behavior proved significant, nor did HIV status.
However, several health and social characteristics were associated with higher odds of prescription opioid misuse,
including substance dependence (OR = 2.911; 95% CI =
1.820, 4.656; p < .000), prior substance abuse treatment
(OR = 1.932; 95% CI = 1.290, 2.894; p = .001), severe
mental distress (OR = 1.718; 95% CI = 1.130, 2.613; p =
.011), victimization (OR = 1.860; 95% CI = 1.058, 3.270;
p = .031), and history of arrest (OR = 2.289; 95% CI =
1.444, 3.629; p < .000).
Significant predictors from the bivariate logistic regression models, in addition to demographics and HIV status, were combined into a multivariate model predicting
recent prescription opioid misuse, shown in Table 3. No
significant associations with prescription opioid misuse
were found with regard to demographics. Substance use
measures of recent binge drinking (OR = 2.473; 95%
CI = 1.777, 5.198; p = .017), cocaine use (OR = 1.944;
95% CI = 1.220, 3.095; p = .005), and drug injection (OR = 2.197; 95% CI = 1.119, 4.312; p = .022)

TABLE 2. Bivariate logistic regression models predicting past
90 day Rx opioid misuse (N = 515)

Demographics
Hispanic
African American/Black
Caucasian/White
Other race/ethnicity
Age(<30 years)
Drug use (past 90 days)
Binge drinking
Cocaine
Crack cocaine
Methamphetamine
Ecstasy
Heroin
Drug injection
Sexual risk behavior (past
90 days)
Partnersa
UAI timesa
Insertive UAI timesa
Receptive UAI timesa
Health and social characteristics
HIV-positive
Substance dependenceb
Substance abuse treatment
history
Severe mental distressb
Victimization history
Arrest history
a
b

p

OR

95% CI

.591
.793
.274
.335
.335

.881
.936
1.250
.774
.774

.554, 1.399
.571, 1.534
.838, 1.863
.460, 1.302
.460, 1.302

.001
.000
.012
.168
.475
.001
.011

2.938
2.329
1.810
1.365
1.202
6.403
2.023

1.513, 5.707
1.546, 3.501
1.137, 2.883
.877, 2.125
.726, 1.990
2.146, 19.104
1.175, 3.483

.761
.774
.736
.141

1.067
.940
.931
1.403

.702, 1.623
.615, 1.436
.613, 1.413
.894, 2.202

.347
.000
.001

.825
2.911
1.932

.553, 1.232
1.820, 4.656
1.290, 2.894

.011
.031
.000

1.718
1.860
2.289

1.130, 2.613
1.058, 3.270
1.444, 3.629

66th percentile.
Past 12 months.

predicted higher odds of prescription opioid misuse during the past 90 days. HIV-positive serostatus was associated with lower odds of prescription opioid misuse during the past 90 days. Substance dependence (OR = 2.150;
TABLE 3. Multivariate logistic regression models predicting past
90 day Rx opioid misuse (N = 515)

Hispanic
African American/Black
Other race/ethnicity
Age (<30 years)
Binge drinkinga
Powder cocainea
Crack cocainea
Heroina
Drug injectiona
HIV-positive
Substance dependenceb
Substance abuse treatment history
Severe mental distressb
Victimization history
Arrest history
a
b

Past 90 days.
Past 12 months.

p

OR

95% CI

.429
.129
.201
.218
.017
.005
.814
.126
.022
.040
.005
.512
.460
.420
.020

.795
.624
.448
.682
2.473
1.944
1.075
2.641
2.197
.604
2.150
1.180
1.202
1.293
1.860

.450, 1.404
.339, 1.148
.131, 1.535
.371, 1.254
1.177, 5.198
1.220, 3.095
.590, 1.957
.767, 9.099
1.119, 4.312
.374, .978
1.253, 3.689
.719, 1.935
.738, 1.960
.692, 2.418
1.100, 3.144
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95% CI = 1.253, 3.689; p = .005) and lifetime history of
arrest (OR = 1.860; 95% CI = 1.100, 3.144; p = .020)
also predicted higher odds of prescription opioid misuse
during the past 90 days.
DISCUSSION

Our analyses from a diverse sample of high risk substanceusing MSM showed that race/ethnicity and age were not
associated with recent prescription opioid misuse. This
contrasts with previous research that documents higher
rates of prescription drug misuse among older MSM
(Kelly & Parsons, 2010; Mackesy-Amiti et al. 2010) and
Caucasian/White individuals in populations of MSM, college students, substance abuse treatment clients, illicit
drug users, and the general population (Benotsch et al.,
2011; Cicero, Inciardi, & Muñoz, 2005; Kelly & Parsons, 2010; McCabe et al., 2006; Miller & Greenfeld,
2004; Simoni-Wastila, Ritter, & Strickler, 2004; Vivian,
Saleheen, SInger, Navarro, & Mirhej, 2005). This divergence may be due to a broader distribution of prescription
opioid misuse among heavy drug users, like those in our
sample.
Prescription opioid misuse was associated with other
substance use including binge drinking, cocaine (both
powder and crack), heroin, and drug injection. Though
our data do not allow us to examine whether prescription opioids were used in combination with other substances, doing so is not an unexceptional practice, and
in such instances it is likely that prescription opioids are
used to moderate the effects of stimulant drugs (Kurtz,
2004). Polydrug use, and especially the combination of illicit and prescription drugs is a dangerous practice (Kurtz,
Inciardi, Surratt, & Cottler, 2005) and can be even more
so when drugs are injected (Havens, Oser, & Leukefeld, 2011; Lankenau, Teti, et al., 2012; Roy, Arruda, &
Bourgois, 2011; Young et al., 2010). Prescription opioid
misuse was associated with recent IDU. Increased risk for
HIV and hepatitis C (HCV) infection due to unsafe injection practices among prescription opioid misusers is
a documented concern (Surratt et al. 2011). Such a scenario increases the risk exposure for an already vulnerable
population.
In the multivariate model, recent prescription opioid
misusers in our sample had lower odds of being HIVpositive. Although at odds with other research, this finding coheres with results of the bivariate logistic regression
models which indicated that prescription opioid misusing
MSM were not more likely to report greater numbers of
sex partners or UAI frequency. Evidence demonstrates an
association between the misuse of prescription drugs in
general and increased sexual risk behavior among MSM
(Benotsch et al., 2011; Kelly & Parsons 2013; MackesyAmiti et al., 2010). However, these studies were conducted with community samples and a household survey, which most likely did not include high risk heavy
substance-using MSM, as did our sample. Further, in ad-
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dition to analgesic properties, individually varying adverse effects of prescription opioids include sedation, respiratory depression, and somnolence (Angst et al., 2012).
As a result, reports of increased sexual risk behavior
among prescription opioid misusers are not apparent in the
literature.
Though the high risk prescription opioid misusing
MSM in our sample did not have higher odds of being HIV-positive, the association between recent prescription opioid misuse and IDU is worrisome. Our data highlight the need to further examine HIV and HCV risk
among high risk heavy substance-using MSM, in order
to better elucidate specific risk factors for HIV transmission related to both sexual risk behavior and IDU. In the
meantime, HIV and HCV prevention and intervention initiatives should be directed toward all high risk MSM,
especially those who report alternate routes of administration of prescription opioids, such as injection.
MSM in our sample reporting recent prescription opioid misuse did have higher odds of reporting substance
dependence, substance abuse treatment history, severe
mental distress, and social risks such as histories of victimization and arrest than men who did not misuse prescription opioids. These findings reveal that even among
heavy substance-using MSM, those who misuse prescription opioids are more likely to experience a host of additional health and social problems than MSM who do
not misuse prescription opioids. This finding is important because, while substance use in general is associated
with many risk factors, the odds of experiencing some of
these health and social problems is greatly increased with
the misuse of prescription opioids. Conversely, high risk
MSM with health and social problems may misuse prescription opioids as a means of self-medication or as a
coping behavior. Regardless of the interpretation, the association between prescription opioid misuse and elevated
health and social problems among high risk substanceusing MSM is a valuable addition to the public health literature. These findings directly respond to observations
that targeted and appropriate responses to prescription
opioid misuse require an understanding of both the reasons for this public health problem and the unique patterns of prescription opioid misuse among specific populations (Gilson, Ryan, Joranson, & Dahl, 2004; Surratt
et al., 2006).
These results should be viewed within the context
of several limitations. Although the recruitment procedures resulted in a sample of a wide age range and
broadly inclusive of the racial/ethnic makeup of South
Florida, our ability to generalize the findings to other
MSM is limited by the study eligibility requirements, including regular substance use and recent UAI. We also
note that all data are based on self-report, potentially
leading to underreporting of socially undesirable behaviors. Given the high levels of substance use and sexual risk behaviors we found, however, underreporting of
these and other stigmatized behaviors would appear to be
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uncommon. Finally, the cross-sectional nature of the data
limits our ability to make causal inferences among the key
variables.
CONCLUSION

This is the first research report to specifically investigate
prescription opioid misuse among high risk MSM. While
several studies have investigated prescription drug misuse among MSM, they have largely found associations
with sexual risk behavior (Benotsch et al., 2011; Kelly
& Parsons, 2013). Our findings advance this research and
demonstrate that a host of other risk factors related specifically to prescription opioid misuse. While we found no
evidence of increased sexual risk behavior among recent
prescription opioid misusers in our sample, data from this
study suggest that men who binge drink and/or use cocaine are more likely to misuse prescription opioids. Risks
related to substance dependence and drug injection could
lead to additional health problems for these men, with
some of the most dangerous and immediate risks being the
development of prescription opioid addiction, experiencing dangerous interactions between several substances,
drug overdose or death, and HIV and HCV infection
(Benotsch et al., 2011; Cai, Crane, Poneleit, & Paulozzi,
2010; CDC, 2012; Hagan, Thiede, & Des Jarlais, 2004;
Miller et al., 2002; Paulozzi, Budnitz, & Xi, 2006).
Because literature suggests that MSM are more likely
to misuse prescription drugs than other men, it would appear likely that prescription opioid misuse among this
population is a growing problem. Given the dangers of
prescription opioid misuse and the alarming number of
past year initiates (CBHSQ, 2012), especially among
young people (SAMHSA, 2011), more attention should be
paid to this public health crisis. Health care providers, especially those who serve MSM, are encouraged to inquire
about patient misuse of prescription opioids and related
health and social problems. Moreover, physicians prescribing opioids should engage in careful patient monitoring and frequent reassessment of risk factors (Pergolizzi
et al., 2012), especially for heavy substance-using MSM.
Risk reduction, mental health, and case management interventions are needed to address the misuse of prescription opioids, the use of other drugs and IDU, as wells as
social risks, such as victimization and arrest history. Future research should investigate the initiation of prescription opioid misuse among MSM in order to bolster education and prevention efforts in this population.
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GLOSSARY

Prescription opioid misuse: Defined as the nonmedical
use of a prescription painkiller, opioid, or analgesic, not
as prescribed. This can include using more than prescribed or using without a prescription.
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